Acer Therapeutics Inc.
USD0.66
-0.14 (-17.95%)
CEO
Christopher Schelling
IPO Date
2004-04-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.80
Prev. Close
$0.80
Day Low
$0.66
Day High
$0.85
52W Low
$0.55
52W High
$4.56
Volume
0.57M
| 125,000 |
| $4.34 |
| 20 Nov 2023 | DUNN JOHN MICHAEL | director | D-Return | Disposed | 27,380 | $4.34 |
| 20 Nov 2023 | ASELAGE STEVE | director | D-Return | Disposed | 483,741 | $4.34 |
| 20 Nov 2023 | Schelling Chris | director, 10 percent owner, officer: PRESIDENT AND CEO | D-Return | Disposed | 2,712,529 | $4.34 |
| 16 Mar 2023 | Joseph Donald | Chief Legal Officer and Secy | A-Award | Acquired | 30,000 | $1.67 |
| 16 Mar 2023 | PALMIN HARRY S | Chief Financial Officer | A-Award | Acquired | 30,000 | $1.67 |
| 16 Mar 2023 | DUNN JOHN MICHAEL | director | A-Award | Acquired | 20,000 | $1.67 |
| 16 Mar 2023 | ASELAGE STEVE | director | A-Award | Acquired | 20,000 | $1.67 |
| 16 Mar 2023 | GRIFFIN MICHELLE RENEE | director | A-Award | Acquired | 20,000 | $1.67 |